Search for: "NEXUS PHARMACEUTICALS, INC." Results 21 - 40 of 58
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jul 2020, 10:00 am by Andrew Hamm
Biomarin Pharmaceutical Inc. 19-1475Issues: (1) Whether a court of appeals can invoke forfeiture to refuse to address an appointments-clause violation in a pending appeal despite an intervening change in law; and (2) whether the U.S. [read post]
21 Jun 2013, 4:46 am by Kedar Bhatia
City of Boca Raton and Burlington Industries, Inc. v. [read post]
11 Aug 2021, 7:00 am by John Holtz
GAO noted, “[t]he protester has articulated no nexus between the HECM regulations and the process for procuring goods or services by federal agencies. [read post]
12 Oct 2017, 8:29 am by Dennis Crouch
” Inequitable Conduct and Regeneron Pharmaceuticals, Inc. v. [read post]
17 Feb 2012, 11:29 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
12 Jun 2014, 10:41 am by Jason Rantanen
Teva Pharmaceuticals USA, Inc. [read post]
11 Aug 2011, 5:25 pm by FDABlog HPM
  APP, in its Reply Brief, however, says otherwise: “The nexus here could not be stronger. [read post]
20 Apr 2021, 4:27 am by Rob Robinson
Druva is a privately held company headquartered in Sunnyvale, California and is funded by Sequoia Capital, Viking Global Investors, CDPQ, Neuberger Berman, Tenaya Capital, Riverwood Capital and Nexus Partners. [read post]
Recent guidance from the Delaware Supreme Court moved away from the fundamentally-identical standard in favor of a stricter adherence to policy language governing relatedness, but the recent Delaware Superior Court decision in Alexion Pharmaceuticals, Inc. v. [read post]